The Weill Cornell Medicine Comprehensive Thalassemia Center staff members are committed to the safety and well-being of our patients. For more information about COVID-19, here are links to other sources: the Weill Cornell COVID-19 patient guide, the Centers for Disease Control (CDC) website, the NYC Department of Health website, and the Cooley's Anemia Foundation website.
These sources provide up-to-date information on signs and symptoms, precautions to take, when to quarantine and other important tips. If you have developed a fever, cough, shortness of breath or other respiratory symptoms, please call your provider right away.
At the New York Comprehensive Thalassemia Center we strive to:
- provide state-of-the-art, multidisciplinary, coordinated, comprehensive clinical care to patients with thalassemia
- further our understanding of thalassemia through research
- offer patients access to cutting-edge clinical trials of novel therapeutics and procedures,
- provide up-to-date, reliable information for patients, providers (primary care and specialty) and the community.